Caryn Lerman: Heinz Josef Lenz and his team identified novel predictive and prognostic biomarkers

Caryn Lerman, Director of USC Norris Comprehensive Cancer Center, shared on LinkedIn:

“Published in the Journal of Clinical Oncology, Dr. Heinz Josef Lenz, Deputy Director for Research Programs at USC Norris, and his team identified novel predictive and prognostic biomarkers to anti- vascular endothelial growth factor and anti- epidermal growth factor receptor antibodies, two key elements in the growth and dissemination of tumors, in a large cooperative clinical trial with a diverse patient population.

The findings have the potential to accelerate drug development strategies and lead to much needed improvement of outcome, particularly in African Americans patients. Read the full publication here.”

For the video attached in the post click here.
Source: Caryn Lerman/LinkedIn